TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Lung Cancer Liquid Biops Market Report & Forecast 2022-2028

Global and United States Lung Cancer Liquid Biops Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 10 October 2022
  • Pages :122
  • Formats:
  • Report Code:SMR-7430494
OfferClick for best price

Best Price: $3480

Lung Cancer Liquid Biops Market Size, Share 2022


Market Analysis and Insights: Global Lung Cancer Liquid Biops Market

The global Lung Cancer Liquid Biops market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lung Cancer Liquid Biops market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lung Cancer Liquid Biops market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lung Cancer Liquid Biops market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lung Cancer Liquid Biops market.

Global Lung Cancer Liquid Biops Scope and Market Size

Lung Cancer Liquid Biops market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Lung Cancer Liquid Biops market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Lung Cancer Liquid Biops market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Exosomes and RNA

CTCs and ctDNA

Segment by Application

Hospitals and Clinics

Physicians'Office Laboratories

Clinical Diagnostic Laboratories

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

By Company

Biocept

EntroGen

Cynvenio Biosystems

Exosome Diagnostics

F. Hoffmann-La Roche

Clearbridge BioMedics

Bio-Rad Laboratories

Agena Bioscience

Cancer Genetics

CellMax Life

Nateras

MedGenome

OncoDNA

Genomic Health

Trovagene

Fluxion Biosciences

Biodesix

Epic Sciences

Shuwen Biotech

Personal Genome Diagnostics

Predicine

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Lung Cancer Liquid Biops product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Lung Cancer Liquid Biops, with price, sales, revenue, and global market share of Lung Cancer Liquid Biops from 2019 to 2022.

Chapter 3, the Lung Cancer Liquid Biops competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Lung Cancer Liquid Biops breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Lung Cancer Liquid Biops market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Lung Cancer Liquid Biops.

Chapter 13, 14, and 15, to describe Lung Cancer Liquid Biops sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Lung Cancer Liquid Biops Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States Lung Cancer Liquid Biops Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 122 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Lung Cancer Liquid Biops Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million) Introduction
1.2 Global Lung Cancer Liquid Biops Outlook 2017 VS 2022 VS 2028
1.2.1 Global Lung Cancer Liquid Biops Market Size for the Year 2017-2028
1.2.2 Global Lung Cancer Liquid Biops Market Size for the Year 2017-2028
1.3 Lung Cancer Liquid Biops Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Lung Cancer Liquid Biops in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Lung Cancer Liquid Biops Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Lung Cancer Liquid Biops Market Dynamics
1.4.1 Lung Cancer Liquid Biops Industry Trends
1.4.2 Lung Cancer Liquid Biops Market Drivers
1.4.3 Lung Cancer Liquid Biops Market Challenges
1.4.4 Lung Cancer Liquid Biops Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Lung Cancer Liquid Biops by Type
2.1 Lung Cancer Liquid Biops Market Segment by Type
2.1.1 Exosomes and RNA
2.1.2 CTCs and ctDNA
2.2 Global Lung Cancer Liquid Biops Market Size by Type (2017, 2022 & 2028)
2.3 Global Lung Cancer Liquid Biops Market Size by Type (2017-2028)
2.4 United States Lung Cancer Liquid Biops Market Size by Type (2017, 2022 & 2028)
2.5 United States Lung Cancer Liquid Biops Market Size by Type (2017-2028)
3 Lung Cancer Liquid Biops by Application
3.1 Lung Cancer Liquid Biops Market Segment by Application
3.1.1 Hospitals and Clinics
3.1.2 Physicians'Office Laboratories
3.1.3 Clinical Diagnostic Laboratories
3.2 Global Lung Cancer Liquid Biops Market Size by Application (2017, 2022 & 2028)
3.3 Global Lung Cancer Liquid Biops Market Size by Application (2017-2028)
3.4 United States Lung Cancer Liquid Biops Market Size by Application (2017, 2022 & 2028)
3.5 United States Lung Cancer Liquid Biops Market Size by Application (2017-2028)
4 Global Lung Cancer Liquid Biops Competitor Landscape by Company
4.1 Global Lung Cancer Liquid Biops Market Size by Company
4.1.1 Top Global Lung Cancer Liquid Biops Companies Ranked by Revenue (2021)
4.1.2 Global Lung Cancer Liquid Biops Revenue by Player (2017-2022)
4.2 Global Lung Cancer Liquid Biops Concentration Ratio (CR)
4.2.1 Lung Cancer Liquid Biops Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Lung Cancer Liquid Biops in 2021
4.2.3 Global Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Lung Cancer Liquid Biops Headquarters, Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million) Type
4.3.1 Global Lung Cancer Liquid Biops Headquarters and Area Served
4.3.2 Global Lung Cancer Liquid Biops Companies Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Lung Cancer Liquid Biops Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Lung Cancer Liquid Biops Market Size by Company
4.5.1 Top Lung Cancer Liquid Biops Players in United States, Ranked by Revenue (2021)
4.5.2 United States Lung Cancer Liquid Biops Revenue by Players (2020, 2021 & 2022)
5 Global Lung Cancer Liquid Biops Market Size by Region
5.1 Global Lung Cancer Liquid Biops Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Lung Cancer Liquid Biops Market Size by Region (2017-2028)
5.2.1 Global Lung Cancer Liquid Biops Market Size by Region: 2017-2022
5.2.2 Global Lung Cancer Liquid Biops Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Lung Cancer Liquid Biops Market Size YoY Growth 2017-2028
6.1.2 North America Lung Cancer Liquid Biops Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Lung Cancer Liquid Biops Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Lung Cancer Liquid Biops Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Lung Cancer Liquid Biops Market Size YoY Growth 2017-2028
6.3.2 Europe Lung Cancer Liquid Biops Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Lung Cancer Liquid Biops Market Size YoY Growth 2017-2028
6.4.2 Latin America Lung Cancer Liquid Biops Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Lung Cancer Liquid Biops Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Lung Cancer Liquid Biops Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Biocept
7.1.1 Biocept Company Details
7.1.2 Biocept Business Overview
7.1.3 Biocept Lung Cancer Liquid Biops Introduction
7.1.4 Biocept Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.1.5 Biocept Recent Development
7.2 EntroGen
7.2.1 EntroGen Company Details
7.2.2 EntroGen Business Overview
7.2.3 EntroGen Lung Cancer Liquid Biops Introduction
7.2.4 EntroGen Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.2.5 EntroGen Recent Development
7.3 Cynvenio Biosystems
7.3.1 Cynvenio Biosystems Company Details
7.3.2 Cynvenio Biosystems Business Overview
7.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Introduction
7.3.4 Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.3.5 Cynvenio Biosystems Recent Development
7.4 Exosome Diagnostics
7.4.1 Exosome Diagnostics Company Details
7.4.2 Exosome Diagnostics Business Overview
7.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Introduction
7.4.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.4.5 Exosome Diagnostics Recent Development
7.5 F. Hoffmann-La Roche
7.5.1 F. Hoffmann-La Roche Company Details
7.5.2 F. Hoffmann-La Roche Business Overview
7.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Introduction
7.5.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.5.5 F. Hoffmann-La Roche Recent Development
7.6 Clearbridge BioMedics
7.6.1 Clearbridge BioMedics Company Details
7.6.2 Clearbridge BioMedics Business Overview
7.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Introduction
7.6.4 Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.6.5 Clearbridge BioMedics Recent Development
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Company Details
7.7.2 Bio-Rad Laboratories Business Overview
7.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Introduction
7.7.4 Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.7.5 Bio-Rad Laboratories Recent Development
7.8 Agena Bioscience
7.8.1 Agena Bioscience Company Details
7.8.2 Agena Bioscience Business Overview
7.8.3 Agena Bioscience Lung Cancer Liquid Biops Introduction
7.8.4 Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.8.5 Agena Bioscience Recent Development
7.9 Cancer Genetics
7.9.1 Cancer Genetics Company Details
7.9.2 Cancer Genetics Business Overview
7.9.3 Cancer Genetics Lung Cancer Liquid Biops Introduction
7.9.4 Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.9.5 Cancer Genetics Recent Development
7.10 CellMax Life
7.10.1 CellMax Life Company Details
7.10.2 CellMax Life Business Overview
7.10.3 CellMax Life Lung Cancer Liquid Biops Introduction
7.10.4 CellMax Life Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.10.5 CellMax Life Recent Development
7.11 Nateras
7.11.1 Nateras Company Details
7.11.2 Nateras Business Overview
7.11.3 Nateras Lung Cancer Liquid Biops Introduction
7.11.4 Nateras Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.11.5 Nateras Recent Development
7.12 MedGenome
7.12.1 MedGenome Company Details
7.12.2 MedGenome Business Overview
7.12.3 MedGenome Lung Cancer Liquid Biops Introduction
7.12.4 MedGenome Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.12.5 MedGenome Recent Development
7.13 OncoDNA
7.13.1 OncoDNA Company Details
7.13.2 OncoDNA Business Overview
7.13.3 OncoDNA Lung Cancer Liquid Biops Introduction
7.13.4 OncoDNA Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.13.5 OncoDNA Recent Development
7.14 Genomic Health
7.14.1 Genomic Health Company Details
7.14.2 Genomic Health Business Overview
7.14.3 Genomic Health Lung Cancer Liquid Biops Introduction
7.14.4 Genomic Health Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.14.5 Genomic Health Recent Development
7.15 Trovagene
7.15.1 Trovagene Company Details
7.15.2 Trovagene Business Overview
7.15.3 Trovagene Lung Cancer Liquid Biops Introduction
7.15.4 Trovagene Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.15.5 Trovagene Recent Development
7.16 Fluxion Biosciences
7.16.1 Fluxion Biosciences Company Details
7.16.2 Fluxion Biosciences Business Overview
7.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Introduction
7.16.4 Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.16.5 Fluxion Biosciences Recent Development
7.17 Biodesix
7.17.1 Biodesix Company Details
7.17.2 Biodesix Business Overview
7.17.3 Biodesix Lung Cancer Liquid Biops Introduction
7.17.4 Biodesix Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.17.5 Biodesix Recent Development
7.18 Epic Sciences
7.18.1 Epic Sciences Company Details
7.18.2 Epic Sciences Business Overview
7.18.3 Epic Sciences Lung Cancer Liquid Biops Introduction
7.18.4 Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.18.5 Epic Sciences Recent Development
7.19 Shuwen Biotech
7.19.1 Shuwen Biotech Company Details
7.19.2 Shuwen Biotech Business Overview
7.19.3 Shuwen Biotech Lung Cancer Liquid Biops Introduction
7.19.4 Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.19.5 Shuwen Biotech Recent Development
7.20 Personal Genome Diagnostics
7.20.1 Personal Genome Diagnostics Company Details
7.20.2 Personal Genome Diagnostics Business Overview
7.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Introduction
7.20.4 Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.20.5 Personal Genome Diagnostics Recent Development
7.21 Predicine
7.21.1 Predicine Company Details
7.21.2 Predicine Business Overview
7.21.3 Predicine Lung Cancer Liquid Biops Introduction
7.21.4 Predicine Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.21.5 Predicine Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Lung Cancer Liquid Biops Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Lung Cancer Liquid Biops Market Trends
Table 3. Lung Cancer Liquid Biops Market Drivers
Table 4. Lung Cancer Liquid Biops Market Challenges
Table 5. Lung Cancer Liquid Biops Market Restraints
Table 6. Global Lung Cancer Liquid Biops Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Lung Cancer Liquid Biops Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Lung Cancer Liquid Biops Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Lung Cancer Liquid Biops Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Lung Cancer Liquid Biops Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Lung Cancer Liquid Biops Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Lung Cancer Liquid Biops Revenue Share by Player, 2017-2022
Table 13. Global Lung Cancer Liquid Biops Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lung Cancer Liquid Biops by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biops as of 2021)
Table 15. Top Players of Lung Cancer Liquid Biops in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Lung Cancer Liquid Biops Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Lung Cancer Liquid Biops Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Lung Cancer Liquid Biops Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Lung Cancer Liquid Biops Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Lung Cancer Liquid Biops Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Lung Cancer Liquid Biops Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Lung Cancer Liquid Biops Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Lung Cancer Liquid Biops Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Lung Cancer Liquid Biops Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Lung Cancer Liquid Biops Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Lung Cancer Liquid Biops Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Lung Cancer Liquid Biops Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Biocept Company Details
Table 31. Biocept Business Overview
Table 32. Biocept Lung Cancer Liquid Biops Product
Table 33. Biocept Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 34. Biocept Recent Development
Table 35. EntroGen Company Details
Table 36. EntroGen Business Overview
Table 37. EntroGen Lung Cancer Liquid Biops Product
Table 38. EntroGen Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 39. EntroGen Recent Development
Table 40. Cynvenio Biosystems Company Details
Table 41. Cynvenio Biosystems Business Overview
Table 42. Cynvenio Biosystems Lung Cancer Liquid Biops Product
Table 43. Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 44. Cynvenio Biosystems Recent Development
Table 45. Exosome Diagnostics Company Details
Table 46. Exosome Diagnostics Business Overview
Table 47. Exosome Diagnostics Lung Cancer Liquid Biops Product
Table 48. Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 49. Exosome Diagnostics Recent Development
Table 50. F. Hoffmann-La Roche Company Details
Table 51. F. Hoffmann-La Roche Business Overview
Table 52. F. Hoffmann-La Roche Lung Cancer Liquid Biops Product
Table 53. F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 54. F. Hoffmann-La Roche Recent Development
Table 55. Clearbridge BioMedics Company Details
Table 56. Clearbridge BioMedics Business Overview
Table 57. Clearbridge BioMedics Lung Cancer Liquid Biops Product
Table 58. Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 59. Clearbridge BioMedics Recent Development
Table 60. Bio-Rad Laboratories Company Details
Table 61. Bio-Rad Laboratories Business Overview
Table 62. Bio-Rad Laboratories Lung Cancer Liquid Biops Product
Table 63. Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 64. Bio-Rad Laboratories Recent Development
Table 65. Agena Bioscience Company Details
Table 66. Agena Bioscience Business Overview
Table 67. Agena Bioscience Lung Cancer Liquid Biops Product
Table 68. Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 69. Agena Bioscience Recent Development
Table 70. Cancer Genetics Company Details
Table 71. Cancer Genetics Business Overview
Table 72. Cancer Genetics Lung Cancer Liquid Biops Product
Table 73. Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 74. Cancer Genetics Recent Development
Table 75. CellMax Life Company Details
Table 76. CellMax Life Business Overview
Table 77. CellMax Life Lung Cancer Liquid Biops Product
Table 78. CellMax Life Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 79. CellMax Life Recent Development
Table 80. Nateras Company Details
Table 81. Nateras Business Overview
Table 82. Nateras Lung Cancer Liquid Biops Product
Table 83. Nateras Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 84. Nateras Recent Development
Table 85. MedGenome Company Details
Table 86. MedGenome Business Overview
Table 87. MedGenome Lung Cancer Liquid Biops Product
Table 88. MedGenome Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 89. MedGenome Recent Development
Table 90. OncoDNA Company Details
Table 91. OncoDNA Business Overview
Table 92. OncoDNA Lung Cancer Liquid Biops Product
Table 93. OncoDNA Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 94. OncoDNA Recent Development
Table 95. Genomic Health Company Details
Table 96. Genomic Health Business Overview
Table 97. Genomic Health Lung Cancer Liquid Biops Product
Table 98. Genomic Health Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 99. Genomic Health Recent Development
Table 100. Trovagene Company Details
Table 101. Trovagene Business Overview
Table 102. Trovagene Lung Cancer Liquid Biops Product
Table 103. Trovagene Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 104. Trovagene Recent Development
Table 105. Fluxion Biosciences Company Details
Table 106. Fluxion Biosciences Business Overview
Table 107. Fluxion Biosciences Lung Cancer Liquid Biops Product
Table 108. Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 109. Fluxion Biosciences Recent Development
Table 110. Biodesix Company Details
Table 111. Biodesix Business Overview
Table 112. Biodesix Lung Cancer Liquid Biops Product
Table 113. Biodesix Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 114. Biodesix Recent Development
Table 115. Epic Sciences Company Details
Table 116. Epic Sciences Business Overview
Table 117. Epic Sciences Lung Cancer Liquid Biops Product
Table 118. Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 119. Epic Sciences Recent Development
Table 120. Shuwen Biotech Company Details
Table 121. Shuwen Biotech Business Overview
Table 122. Shuwen Biotech Lung Cancer Liquid Biops Product
Table 123. Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 124. Shuwen Biotech Recent Development
Table 125. Personal Genome Diagnostics Company Details
Table 126. Personal Genome Diagnostics Business Overview
Table 127. Personal Genome Diagnostics Lung Cancer Liquid Biops Product
Table 128. Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 129. Personal Genome Diagnostics Recent Development
Table 130. Predicine Company Details
Table 131. Predicine Business Overview
Table 132. Predicine Lung Cancer Liquid Biops Product
Table 133. Predicine Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million)
Table 134. Predicine Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Lung Cancer Liquid Biops Product Picture
Figure 2. Global Lung Cancer Liquid Biops Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Lung Cancer Liquid Biops Market Size 2017-2028 (US$ Million)
Figure 4. United States Lung Cancer Liquid Biops Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Lung Cancer Liquid Biops Market Size 2017-2028 (US$ Million)
Figure 6. United States Lung Cancer Liquid Biops Market Share in Global 2017-2028
Figure 7. Lung Cancer Liquid Biops Report Years Considered
Figure 8. Product Picture of Exosomes and RNA
Figure 9. Product Picture of CTCs and ctDNA
Figure 10. Global Lung Cancer Liquid Biops Market Share by Type in 2022 & 2028
Figure 11. Global Lung Cancer Liquid Biops Market Size by Type (2017-2028) & (US$ Million)
Figure 12. Global Lung Cancer Liquid Biops Market Share by Type (2017-2028)
Figure 13. United States Lung Cancer Liquid Biops Market Share by Type in 2022 & 2028
Figure 14. United States Lung Cancer Liquid Biops Market Size by Type (2017-2028) & (US$ Million)
Figure 15. United States Lung Cancer Liquid Biops Market Share by Type (2017-2028)
Figure 16. Product Picture of Hospitals and Clinics
Figure 17. Product Picture of Physicians'Office Laboratories
Figure 18. Product Picture of Clinical Diagnostic Laboratories
Figure 19. Global Lung Cancer Liquid Biops Market Share by Application in 2022 & 2028
Figure 20. Global Lung Cancer Liquid Biops Market Size by Application (2017-2028) & (US$ Million)
Figure 21. Global Lung Cancer Liquid Biops Market Share by Application (2017-2028)
Figure 22. United States Lung Cancer Liquid Biops Market Share by Application in 2022 & 2028
Figure 23. United States Lung Cancer Liquid Biops Market Size by Application (2017-2028) & (US$ Million)
Figure 24. United States Lung Cancer Liquid Biops Market Share by Application (2017-2028)
Figure 25. North America Lung Cancer Liquid Biops Market Size Growth Rate 2017-2028 (US$ Million)
Figure 26. U.S. Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 27. Canada Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Europe Lung Cancer Liquid Biops Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. Germany Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. France Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. U.K. Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Italy Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Russia Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Lung Cancer Liquid Biops Market Size Growth Rate 2017-2028 (US$ Million)
Figure 35. China Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Japan Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. South Korea Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. India Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Australia Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Taiwan Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Indonesia Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Thailand Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Malaysia Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Philippines Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Latin America Lung Cancer Liquid Biops Market Size Growth Rate 2017-2028 (US$ Million)
Figure 46. Mexico Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Brazil Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Argentina Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Lung Cancer Liquid Biops Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Turkey Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. UAE Lung Cancer Liquid Biops Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Biocept Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 54. EntroGen Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 55. Cynvenio Biosystems Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 56. Exosome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 57. F. Hoffmann-La Roche Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 58. Clearbridge BioMedics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 59. Bio-Rad Laboratories Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 60. Agena Bioscience Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 61. Cancer Genetics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 62. CellMax Life Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 63. Nateras Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 64. MedGenome Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 65. OncoDNA Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 66. Genomic Health Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 67. Trovagene Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 68. Fluxion Biosciences Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 69. Biodesix Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 70. Epic Sciences Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 71. Shuwen Biotech Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 72. Personal Genome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 73. Predicine Revenue Growth Rate in Lung Cancer Liquid Biops Business (2017-2022)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount